| Basic model* | Adjusted model†| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | (i)Metabolic syndrome | (ii)Number of components present | (i)Metabolic syndrome | (ii)Number of components present | ||||||||
 | B (95% CI) | P | R2 | B (95% CI) | P# | R2 | B (95% CI) | P | R2 | B (95% CI) | P# | R2 |
IMTcc (mm) | 0.03 (0.00 to 0.05) | 0.02 | 0.278 | 0.02 (0.01 to 0.03) | <0.001 | 0.286 | 0.02 (0.00 to 0.04) | 0.047 | 0.287 | 0.02 (0.01 to 0.02) | <0.001 | 0.296 |
(ln)SPA | 0.24 (0.002 to 0.47) | 0.048 | 0.330 | 0.17 (0.07 to 0.26) | <0.001 | 0.337 | 0.22 (−0.015 to 0.45) | 0.07 | 0.344 | 0.16 (0.07 to 0.25) | 0.001 | 0.351 |
(ln)SPAcar | 0.15 (−0.07 to 0.38) | 0.18 | 0.234 | 0.10 (0.01 to 0.19) | 0.03 | 0.237 | 0.16 (−0.07 to 0.38) | 0.17 | 0.241 | 0.10 (0.01 to 0.19) | 0.03 | 0.244 |
(ln)SPAfem | 0.26 (0.02 to 0.50) | 0.03 | 0.303 | 0.15 (0.05 to 0.24) | 0.003 | 0.307 | 0.24 (0.004 to 0.48) | 0.046 | 0.333 | 0.14 (0.05 to 0.24) | 0.003 | 0.337 |
 | OR (95% CI) | P | R 2 | OR (95% CI) | P | R 2 | OR (95% CI) | P | R 2 | OR (95% CI) | P | R 2 |
Plaque Presence (0 Vs 1–4) | 1.42 (0.93 to 2.16) | 0.10 | 0.303 | 1.27 (1.08 to 1.5) | <0.001 | 0.319 | 1.38 (0.91 to 2.12) | 0.13 | 0.312 | 1.25 (1.06 to 1.48) | 0.008 | 0.326 |